NCCTG N057K phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: A North Central Cancer Treatment Group trial.

被引：0
|
作者：
Ma, Daniel
Galanis, Evanthia
Schiff, David
Wu, Wenting
Peller, Patrick J.
Giannini, Caterina
Brown, Paul D.
Uhm, Joon H.
McGraw, Steven
Jaeckle, Kurt A.
Flynn, Patrick J.
Buckner, Jan C.
Sarkaria, Jann Nagina
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Univ Virginia, Med Ctr, Charlottesville, VA USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Sioux Community Canc Consortium, Sioux Falls, SD USA
[5] Mayo Clin, Jacksonville, FL 32224 USA
[6] Metro Minnesota Community Clin Oncol Project, St Louis Pk, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2031
引用
收藏
页数：1
相关论文
共 50 条
  • [31] SYMPTOM BURDEN IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA UNDERGOING RADIOTHERAPY PLUS TEMOZOLOMIDE AND ENZASTAURIN: RESULTS FROM A PHASE I/II TRIAL
    Butowski, Nicholas
    Parvataneni, Rupa
    Nicole, Angelina
    Lamborn, Kathleen
    Polley, Mei
    Clarke, Jennifer
    Chang, Susan
    Page, Margaretta
    Prados, Michael
    Liepa, Astra
    Shi, P.
    Thornton, Donald
    NEURO-ONCOLOGY, 2010, 12 : 104 - 104
  • [32] Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial)
    Supriya Mallick
    Haresh Kunhiparambath
    Subhash Gupta
    Rony Benson
    Seema Sharma
    M. A. Laviraj
    Ashish Datt Upadhyay
    Pramod Kumar Julka
    Dayanand Sharma
    Goura Kishor Rath
    Journal of Neuro-Oncology, 2018, 140 : 75 - 82
  • [33] Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial)
    Mallick, Supriya
    Kunhiparambath, Haresh
    Gupta, Subhash
    Benson, Rony
    Sharma, Seema
    Laviraj, M. A.
    Upadhyay, Ashish Datt
    Julka, Pramod Kumar
    Sharma, Dayanand
    Rath, Goura Kishor
    JOURNAL OF NEURO-ONCOLOGY, 2018, 140 (01) : 75 - 82
  • [34] Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
    Galanis, Evanthia
    Jaeckle, Kurt A.
    Maurer, Matthew J.
    Reid, Joel M.
    Ames, Matthew M.
    Hardwick, James S.
    Reilly, John F.
    Loboda, Andrey
    Nebozhyn, Michael
    Fantin, Valeria R.
    Richon, Victoria M.
    Scheithauer, Bernd
    Giannini, Caterina
    Flynn, Patrick J.
    Moore, Dennis F., Jr.
    Zwiebel, James
    Buckner, Jan C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) : 2052 - 2058
  • [35] Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma
    Biau, J.
    Thivat, E.
    Chautard, E.
    Stefan, D.
    Boone, M.
    Chauffert, B.
    Bourgne, C.
    Richard, D.
    Molnar, I
    Levesque, S.
    Bellini, R.
    Kwiatkowski, F.
    Karayan-Tapon, L.
    Verrelle, P.
    Godfraind, C.
    Durando, X.
    RADIOTHERAPY AND ONCOLOGY, 2021, 154 : 227 - 234
  • [36] PriCoTTF Trial: A phase I/II trial of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma
    Kebir, S.
    Lazaridis, L.
    Schmidt, T.
    Oster, C.
    Pierscianek, D.
    Guberina, N.
    Kleinschnitz, C.
    Proescholdt, M.
    Hau, P.
    Grosu, A. -L
    Sure, U.
    Scheffler, B.
    Stuschke, M.
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S74 - S74
  • [37] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Kebir, Sied
    Pierscianek, Daniela
    Proescholdt, Martin
    Hau, Peter
    Grosu, Anca-Ligia
    Krex, Dietmar
    Sure, Ulrich
    Scheffler, Bjoern
    Stuschke, Martin
    Glas, Martin
    NEURO-ONCOLOGY, 2021, 23 : 68 - 68
  • [38] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Kebir, S.
    Pierscianek, D.
    Proescholdt, M.
    Hau, P.
    Grosu, A.
    Krex, D.
    Sure, U.
    Scheffler, B.
    Stuschke, M.
    Glas, M.
    NEURO-ONCOLOGY, 2021, 23 : 50 - 50
  • [39] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Kebir, Sied
    Lazaridis, Lazaros
    Schmidt, Teresa
    Oster, Christoph
    Pierscianek, Daniela
    Guberina, Nika
    Kleinschnitz, Christoph
    Proescholdt, Martin
    Hau, Peter
    Grosu, Anca-Ligia
    Sure, Ulrich
    Scheffler, Bjoern
    Stuschke, Martin
    Glas, Martin
    NEURO-ONCOLOGY, 2020, 22 : 61 - 61
  • [40] MRI CHANGES IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED AS PART OF A PHASE II TRIAL WITH BAVITUXIMAB, RADIATION, AND TEMOZOLOMIDE
    Ly, Ina
    Cardona, Jonathan
    Beers, Andrew
    Chang, Ken
    Brown, James
    Reardon, David
    Arrillaga-Romany, Isabel
    Dietrich, Jorg
    Forst, Deborah
    Lee, Eudocia
    Jordan, Justin
    Nayak, Lakshmi
    Wen, Patrick
    Batchelor, Tracy
    Kalpathy-Cramer, Jayashree
    Gerstner, Elizabeth
    NEURO-ONCOLOGY, 2018, 20 : 191 - 191
12345